Literature DB >> 26605933

Resolvin Infectious Inflammation by Targeting the Host Response.

Craig R Lee, Darryl C Zeldin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26605933      PMCID: PMC5512422          DOI: 10.1056/NEJMcibr1511280

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  Severe sepsis and septic shock.

Authors:  Derek C Angus; Tom van der Poll
Journal:  N Engl J Med       Date:  2013-08-29       Impact factor: 91.245

Review 2.  Sepsis: a roadmap for future research.

Authors:  Jonathan Cohen; Jean-Louis Vincent; Neill K J Adhikari; Flavia R Machado; Derek C Angus; Thierry Calandra; Katia Jaton; Stefano Giulieri; Julie Delaloye; Steven Opal; Kevin Tracey; Tom van der Poll; Eric Pelfrene
Journal:  Lancet Infect Dis       Date:  2015-04-19       Impact factor: 25.071

Review 3.  Statin therapy and mortality from sepsis: a meta-analysis of randomized trials.

Authors:  Abhishek Deshpande; Vinay Pasupuleti; Michael B Rothberg
Journal:  Am J Med       Date:  2014-12-17       Impact factor: 4.965

Review 4.  Pro-resolving lipid mediators are leads for resolution physiology.

Authors:  Charles N Serhan
Journal:  Nature       Date:  2014-06-05       Impact factor: 49.962

5.  Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections.

Authors:  Jesmond Dalli; Nan Chiang; Charles N Serhan
Journal:  Nat Med       Date:  2015-08-03       Impact factor: 53.440

  5 in total
  26 in total

Review 1.  Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology.

Authors:  Charles N Serhan
Journal:  Mol Aspects Med       Date:  2017-03-03

Review 2.  New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration.

Authors:  Charles N Serhan; Nan Chiang; Jesmond Dalli
Journal:  Mol Aspects Med       Date:  2017-09-01

Review 3.  Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators.

Authors:  Charles N Serhan; Bruce D Levy
Journal:  J Clin Invest       Date:  2018-05-14       Impact factor: 14.808

Review 4.  Specialized pro-resolving mediator network: an update on production and actions.

Authors:  Nan Chiang; Charles N Serhan
Journal:  Essays Biochem       Date:  2020-09-23       Impact factor: 8.000

Review 5.  Specialized Proresolving Mediators in Innate and Adaptive Immune Responses in Airway Diseases.

Authors:  Nandini Krishnamoorthy; Raja-Elie E Abdulnour; Katherine H Walker; Braden D Engstrom; Bruce D Levy
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

6.  Proresolving lipid mediators enhance PMN-mediated bacterial clearance.

Authors:  Lucy V Norling; Mauro Perretti
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-16       Impact factor: 11.205

Review 7.  Metabololipidomic profiling of functional immunoresolvent clusters and eicosanoids in mammalian tissues.

Authors:  Paul C Norris; Charles N Serhan
Journal:  Biochem Biophys Res Commun       Date:  2018-03-15       Impact factor: 3.575

Review 8.  The immune system's role in sepsis progression, resolution, and long-term outcome.

Authors:  Matthew J Delano; Peter A Ward
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

Review 9.  Immune resolution mechanisms in inflammatory arthritis.

Authors:  Mauro Perretti; Dianne Cooper; Jesmond Dalli; Lucy V Norling
Journal:  Nat Rev Rheumatol       Date:  2017-01-05       Impact factor: 20.543

10.  Commercial scale production of RvD4 opens the resolving door to new research.

Authors:  Matthew L Edin; Darryl C Zeldin
Journal:  J Leukoc Biol       Date:  2018-03-30       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.